Effect of monoamine oxidase A and B and of catechol-O-methyltransferase inhibition on L-DOPA-indnced circling behavior

被引:11
作者
Heeringa, MJ [1 ]
dAgostini, F [1 ]
DeBoer, P [1 ]
DaPrada, M [1 ]
Damsma, G [1 ]
机构
[1] F HOFFMANN LA ROCHE & CO LTD,PHARMACEUT RES DEPT,CH-4002 BASEL,SWITZERLAND
关键词
monoamine oxidase; catechol-O-methyltransferase; Ro; 41-1049; 19-6327; 40-7592; Parkinson's disease; 6-hydroxydopamine; behavior;
D O I
10.1007/BF01291878
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The effect of enzyme-inhibiting adjuvants on L-DOPA + benserazide-induced contralateral turning in unilateral 6-hydroxydopamine (6-OHDA)-lesioned rats was studied. Both the number of turns and the duration of turning were examined. Inhibition of MAO-A with 10 mg/kg Ro 41-1049 increased both parameters; inhibition of COMT with 30 mg/kg Ro 40-7592 had a similar effect. In contrast, inhibition of MAO-B with 10 mg/kg Ro 19-6327 did not change turning behavior. A further potentiation of turning behavior was observed after the combined administration of both the MAO-A and COMT inhibitor. MAO-A inhibition in conjunction with MAO-B inhibition prolonged the duration of L-DOPA-induced turning but had no effect on the number of turns. However, in conjunction with COMT inhibition, 10 mg/kg of the MAO-B inhibitor, Ro 19-6327, significantly affected both the number and duration of turning behavior. An even further potentiation of turning behavior was observed after the combined administration of all three enzyme-inhibitors.
引用
收藏
页码:593 / 603
页数:11
相关论文
共 55 条
[31]  
Konig J.F.R., 1963, RAT BRAIN STEREOTAXI
[32]   IMMUNO-CYTOCHEMICAL DEMONSTRATION OF MONOAMINE OXIDASE-B IN BRAIN ASTROCYTES AND SEROTONERGIC NEURONS [J].
LEVITT, P ;
PINTAR, JE ;
BREAKEFIELD, XO .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (20) :6385-6389
[33]   RO-40-7592, A COMT INHIBITOR, PLUS LEVODOPA IN PARKINSONS-DISEASE [J].
LIMOUSIN, P ;
POLLAK, P ;
GERVASONTOURNIER, CL ;
HOMMEL, M ;
PERRET, JE .
LANCET, 1993, 341 (8860) :1605-1605
[34]  
LINDEN IB, 1988, J PHARMACOL EXP THER, V247, P289
[35]   BEHAVIORAL AND NEUROCHEMICAL EFFECTS OF RO 40-7592, A NEW COMT INHIBITOR WITH A POTENTIAL THERAPEUTIC ACTIVITY IN PARKINSONS-DISEASE [J].
MAJ, J ;
ROGOZ, Z ;
SKUZA, G ;
SOWINSKA, H ;
SUPERATA, J .
JOURNAL OF NEURAL TRANSMISSION-PARKINSONS DISEASE AND DEMENTIA SECTION, 1990, 2 (02) :101-112
[36]  
MANNISTO PT, 1991, N-S ARCH PHARMACOL, V344, P412
[37]   INHIBITION OF CATECHOL-O-METHYLTRANSFERASE ACTIVITY BY 2 NOVEL DISUBSTITUTED CATECHOLS IN THE RAT [J].
NISSINEN, E ;
LINDEN, IB ;
SCHULTZ, E ;
KAAKKOLA, S ;
MANNISTO, PT ;
POHTO, P .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 153 (2-3) :263-269
[38]  
*PARK STUD GROUP, 1994, ARCH NEUROL-CHICAGO, V51, P342
[39]  
*PARK STUD GROUP, 1993, ANN NEUROL, V33, P350
[40]   TURNING IN MFB-LESIONED RATS AND ANTAGONISM OF NEUROLEPTIC-INDUCED CATALEPSY AFTER LISURIDE AND LSD [J].
PIERI, M ;
SCHAFFNER, R ;
PIERI, L ;
DAPRADA, M ;
HAEFELY, W .
LIFE SCIENCES, 1978, 22 (18) :1615-1622